Home › Colon Cancer › Florida › Tampa
Pag-aaral pangklinika para sa Colon Cancer sa Tampa, FL
Isang pag-aaral para sa Colon Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Tampa. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Nagre-recruitPhase 1
- ALX Center 7, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Nagre-recruitPhase 3
- Tampa General Hospital-Cancer Institute, Tampa
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Nagre-recruitPhase 2/3
- Tampa General Hospital, Tampa
- Moffitt Cancer Center-International Plaza, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
- at 2 pa
Shield Post-Approval Study Protocol
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- NMC Research, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
Nagre-recruit
- Tampa General Hospital, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Nagre-recruitPhase 1
- Lee Moffitt Cancer Center, Tampa
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
Pag-aaral para sa Colon Cancer sa ibang lungsod
- Boston, MA22 pag-aaral
- New York City, NY22 pag-aaral
- Houston, TX20 pag-aaral
- Los Angeles, CA16 pag-aaral
- Nashville, TN16 pag-aaral
- St. Louis, MO15 pag-aaral
- Arlington, VA15 pag-aaral
- Chicago, IL14 pag-aaral
- San Antonio, TX14 pag-aaral
- Baldwin Park, CA14 pag-aaral
- Baltimore, MD13 pag-aaral
- Washington, DC12 pag-aaral
Iba pang pag-aaral sa Tampa
- Non-Small Cell Lung Cancer51 pag-aaral
- Kanser sa Suso43 pag-aaral
- Kanser (lahat ng uri)39 pag-aaral
- Colorectal Cancer34 pag-aaral
- Acute Myeloid Leukemia29 pag-aaral
- Metastatic Cancer29 pag-aaral
- Kanser sa Baga29 pag-aaral
- Kanser sa Pancreas26 pag-aaral
- Kanser sa Ovary21 pag-aaral
- Melanoma19 pag-aaral
- Myelodysplastic Syndromes19 pag-aaral
- Kanser sa Prostate18 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.